Navigation Links
Omeros Corporation Reports First Quarter 2013 Financial Results
Date:5/10/2013

SEATTLE, May 10, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER), a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system, today announced its financial results for the first quarter of 2013.

Financial ResultsTotal operating expenses for the quarter ended March 31, 2013 were $11.1 million compared to $9.6 million for the same period in 2012. The increase is primarily due to research and development expenses associated with advancing Omeros' MASP-2 program toward the clinic, employee costs and non-cash rent expense, and to selling, general and administrative expenses related to legal matters and Omeros' planned commercial launch of OMS302 in 2014.  These higher costs were partially offset by lower clinical trial expenses related to the completion of Phase 3 clinical trials for Omeros' OMS302 and OMS103HP programs in January 2013 and December 2012, respectively.  For the quarter ended March 31, 2013, Omeros reported a net loss of $10.5 million, or $0.40 per share, compared to a net loss of $8.9 million, or $0.40 per share, for the same period in 2012.

At March 31, 2013, Omeros had cash, cash equivalents and short-term investments of $13.3 million. On May 9, Omeros announced that it priced a public offering of 3,903,004 shares of its common stock at a price of $4.14 per share, a two percent premium over the closing price on May 8, 2013, for estimated net proceeds of $16.1 million. The offering is expected to close on or about May 14, 2013. The shares were offered and are expected to be sold to RA Capital Management and other investors in a registered direct offering conducted without an underwriter or placement agent. Omeros also did not use its at-the-market sales facility or its committed
'/>"/>

SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Omeros Announces $16.2 Million Registered Direct Offering of Common Stock
2. Omeros Ophthalmology Product OMS302 Granted Eligibility for European Centralized Review
3. Omeros to Present Additional OMS302 Clinical Data at the Annual ASCRS and ASOA Symposium and Congress
4. Omeros Files Orphan Drug Application for Treatment of Atypical Hemolytic Uremic Syndrome with OMS721
5. Omeros Announces that GPR17 Antagonists Improve Function in Model of Multiple Sclerosis
6. Omeros Announces Positive OMS721 Data in Model of Thrombotic Microangiopathy
7. Omeros to Present at the 2013 Future Leaders in the Biotech Industry Conference
8. Omeros Announces Toxicology Data that Support Advancing MASP-2 Inhibitor into Clinical Trials
9. Omeros Announces Successful Completion of PDE10 Phase 1 Multiple Ascending Dose Trial
10. Omeros Elucidates Mechanism of its PDE7 Inhibitors in Addiction
11. Omeros to Present at the Cowen and Company 33rd Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... Calif. and REHOVOT, Israel, Sept. 3, 2015 ... on acquiring and developing innovative therapies for ear, nose, ... the Irvine Company,s Newport Gateway office complex to be ... to complete the move by end of September and ... U.S. Headquarters: OticPharma, Inc. 19900 ...
(Date:9/2/2015)... YORK , Sept. 2, 2015  The report ... future market of breast cancer drugs on the basis ... cancer usually originates from the inner lining of milk ... is a malignant type of tumor that can spread ... of cancer which starts in lobules is referred as ...
(Date:9/2/2015)... -- Advanced Wound Dressings - 5EU Analysis and ... steadily replaced traditional bandages and gauze materials in ... such as trauma wounds, burns, and chronic ulcerations. ... become increasingly critical in wound healing, advanced dressings ... This report focuses on nine market categories within ...
Breaking Medicine Technology:OticPharma Establishes U.S. Headquarters in Orange County, California 2Breast Cancer Therapeutics: Pipeline Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 2Breast Cancer Therapeutics: Pipeline Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 3Advanced Wound Dressings - 5EU Analysis and Market Forecasts 2
(Date:9/3/2015)... ... September 03, 2015 , ... ... data collection, cloud analytics and workflow solutions today announced the complete faculty ... September 22-24, 2015. The esteemed faculty of worldwide pharmaceutical and industry experts ...
(Date:9/3/2015)... ... 2015 , ... AvePoint, the established leader in enabling enterprise collaboration ... – AvePoint’s solution for facilitating two-way collaboration and external sharing without ever having ... This is the fifth consecutive year an AvePoint product has made the list. , ...
(Date:9/3/2015)... ... September 03, 2015 , ... The new ... Report of Provo, Utah. The Clinicians Report is a leading information source to ... located throughout the U.S. Whiter Image's In-Office whitening kits were favorably validated for ...
(Date:9/3/2015)... ... ... Local filmmakers and now co-hosts of the up and coming podcast Path11 Podcast ... great success in launching their Path11 Podcast with 23 episodes released since April 2015. ... the well known Spiritual Catalyst and Linda Howe, leader in the field of Akashic ...
(Date:9/3/2015)... ... , ... The partnership will leverage Fidson’s strong and experienced ... promote LodonalTM in Nigeria. The distribution will become effective, upon completion of the ... product. , Managing Director, Fidson Healthcare Plc, Dr Fidelis Ayebae, expressed that “Fidson ...
Breaking Medicine News(10 mins):Health News:ERT Announces Final Agenda, Faculty for European PRO / eCOA Congress 2Health News:ERT Announces Final Agenda, Faculty for European PRO / eCOA Congress 3Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 2Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 3Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 4Health News:Whiter Image Products Get Positive Rating From The Clinicians Report 2Health News:Path 11 Podcast Now Features over 20 Metaphysical Discussions on iTunes and Growing 2Health News:Path 11 Podcast Now Features over 20 Metaphysical Discussions on iTunes and Growing 3Health News:Fidson Partners US Firms on New Product Marketing 2Health News:Fidson Partners US Firms on New Product Marketing 3Health News:Fidson Partners US Firms on New Product Marketing 4
... Presentation at March 17 Citi Conference, CHICAGO, March ... today announced that management will make a presentation,regarding the ... March 19, 2008 at 9:00 a.m. ET at the ... presentation is being webcast live and can be accessed ...
... LAKE, Minn., March 13 Kohler Mix Specialties,of ... recalling bulk,464-count cases of 3/8 fluid ounce cups ... date of 4/08/2008, "Reorder No." 427233 and,Universal Product ... individual cups in the bulk cases may be ...
... Lung Cancer Research Bill Given Hearing in,Joint Committee ... Lung Cancer,Alliance praised the efforts of State Senator ... funding bill through the,Massachusetts State Senate Committee on ... known as the Commonwealth Lung Cancer Early,Detection and ...
... behavior, dealt better with stress , , THURSDAY, March 13 ... may be more likely to have an easygoing child, ... data on more than 18,000 children born in the ... habits during pregnancy were noted, and they were classified ...
... innovator,Kenneth A. Bock, M.D., founder of The Rhinebeck ... EPIDEMICS, today announced that he has formed The,4-A ... of families of,children who are affected by the ... believes that these four childhood epidemics can be,treated ...
... Inc.,(Nasdaq: VTAL ), a leading provider of ... it is pleased that,the Centers for Medicare & ... national reimbursement coverage of cardiac computed tomography,angiography (CCTA) ... coverage. This innovative procedure combines a CT scan ...
Cached Medicine News:Health News:Brookdale to Present at Lehman Global Healthcare Conference on March 19 2Health News:Allergy Alert on Undeclared Soy Ingredient in Bulk Cases of GFS Ultra-Pasteurized Non-Dairy Creamer 2Health News:Lung Cancer Alliance Commends Leadership of MA State Senate 2Health News:Moms-to-Be Who Quit Smoking Boost Chances for 'Easygoing' Child 2Health News:Leading Autism Expert Kenneth A. Bock, M.D. Launches National Foundation to Provide Financial Assistance to Children with Autism, Allergies, Asthma and ADHD 2Health News:Vital Images Comments on CMS Decision to Allow Local Coverage for Cardiac CT Angiography 2Health News:Vital Images Comments on CMS Decision to Allow Local Coverage for Cardiac CT Angiography 3
... Equally Spaced, Expandable, Multichannel Pipettor ... instantly boosts productivity with an industry breakthroughequal ... adjustment of a slide rod. This innovation ... liquids between vessels with different configurations. ...
... Ergonomic Design for Unparalleled Comfort Pick one ... the balance. Notice the trigger and ejector positionsright ... because our pipettors are ergonomically designed to help ... of pipetting. Productivity In The Palm Of ...
... ergonomic solution and best value in high ... action and ultra lightweight design reduce hand ... with long, lever tip ejector , Color ... universal tips or for greater performance use ...
... ergonomic solution and best value in high ... action and ultra lightweight design reduce hand ... with long, lever tip ejector , Color ... universal tips or for greater performance use ...
Medicine Products: